{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:47:06Z","timestamp":1784036826149,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11926-y","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T11:46:16Z","timestamp":1761651976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Epidemiology, resistance profiles, and risk factors of multidrug-resistant Klebsiella pneumoniae: experience from a low- and middle-income country"],"prefix":"10.1186","volume":"25","author":[{"given":"Banan M.","family":"Aiesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruba","family":"Jomaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Zouneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dania","family":"Abuhalima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motaz","family":"Saifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraqat","family":"Namrouti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adham","family":"Abutaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moutaz W.","family":"Sweileh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samah W.","family":"Al-Jabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Sabateen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa\u2019ed H.","family":"Zyoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"11926_CR1","unstructured":"World Health Organization. Antimicrobial Resistance. 2023. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance (accessed July 1 2025)."},{"issue":"11","key":"11926_CR2","doi-asserted-by":"publisher","first-page":"e1002184","DOI":"10.1371\/journal.pmed.1002184","volume":"13","author":"ME de Kraker","year":"2016","unstructured":"de Kraker ME, Stewardson AJ, Harbarth S. Will 10 million people die a year due to antimicrobial resistance by 2050? PLoS Med. 2016;13(11):e1002184.","journal-title":"PLoS Med"},{"key":"11926_CR3","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU\/EEA (EARS-Net) - Annual epidemiological report for 2022. 2023. Available from: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/surveillance-antimicrobial-resistance-europe-2022 (accessed July 1 2025)."},{"key":"11926_CR4","unstructured":"National Academies Press. The health and economic burden of resistance. Combating antimicrobial resistance and protecting the miracle of modern medicine. Edited by Palmer GH BG; 2021."},{"issue":"3","key":"11926_CR5","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3934\/microbiol.2018.3.482","volume":"4","author":"WC Reygaert","year":"2018","unstructured":"Reygaert WC. An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiol. 2018;4(3):482\u2013501.","journal-title":"AIMS Microbiol"},{"key":"11926_CR6","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.2147\/IDR.S234610","volume":"12","author":"P Dadgostar","year":"2019","unstructured":"Dadgostar P. Antimicrobial resistance: implications and costs. Infect Drug Resist. 2019;12:3903\u201310.","journal-title":"Infect Drug Resist"},{"issue":"10","key":"11926_CR7","doi-asserted-by":"publisher","first-page":"e27517","DOI":"10.5812\/jjm.27517","volume":"8","author":"AS Moini","year":"2015","unstructured":"Moini AS, Soltani B, Taghavi Ardakani A, Moravveji A, Erami M, Haji Rezaei M, Namazi M. Multidrug-resistant Escherichia coli and Klebsiella pneumoniae isolated from patients in Kashan, Iran. Jundishapur J Microbiol. 2015;8(10):e27517.","journal-title":"Jundishapur J Microbiol"},{"issue":"2","key":"11926_CR8","doi-asserted-by":"publisher","first-page":"505","DOI":"10.4314\/ahs.v21i2.4","volume":"21","author":"KC Mofolorunsho","year":"2021","unstructured":"Mofolorunsho KC, Ocheni HO, Aminu RF, Omatola CA, Olowonibi OO. Prevalence and antimicrobial susceptibility of extended-spectrum beta lactamases-producing Escherichia coli and Klebsiella pneumoniae isolated in selected hospitals of Anyigba, Nigeria. Afr Health Sci. 2021;21(2):505\u201312.","journal-title":"Afr Health Sci"},{"issue":"1","key":"11926_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12941-019-0343-8","volume":"19","author":"CY Effah","year":"2020","unstructured":"Effah CY, Sun T, Liu S, Wu Y. Klebsiella pneumoniae: an increasing threat to public health. Ann Clin Microbiol Antimicrob. 2020;19(1):1.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"3","key":"11926_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.5144\/0256-4947.2005.239","volume":"25","author":"AA Kader","year":"2005","unstructured":"Kader AA, Kumar A. Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital. Ann Saudi Med. 2005;25(3):239\u201342.","journal-title":"Ann Saudi Med"},{"key":"11926_CR11","unstructured":"Elsevier. Carbapenem \u2013 an overview. 2019. Available from: https:\/\/www.sciencedirect.com\/topics\/medicine-and-dentistry\/carbapenem (accessed July 1 2025)."},{"key":"11926_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2147\/IDR.S391409","volume":"16","author":"EH Yoo","year":"2023","unstructured":"Yoo EH, Hong HL, Kim EJ. Epidemiology and mortality analysis related to Carbapenem-resistant enterobacterales in patients after admission to intensive care units: an observational study. Infect Drug Resist. 2023;16:189\u2013200.","journal-title":"Infect Drug Resist"},{"key":"11926_CR13","unstructured":"Smith H, Hollingshead C, Kendall B. Carbapenem-resistant enterobacterales. In.: StatPearls Publishing; 2024."},{"key":"11926_CR14","doi-asserted-by":"crossref","unstructured":"Mohd Asri NA, Ahmad S, Mohamud R, Mohd Hanafi N, Mohd Zaidi NF, Irekeola AA, Shueb RH, Yee LC, Mohd Noor N, Mustafa FH et al. Global prevalence of nosocomial multidrug-resistant Klebsiella pneumoniae: a systematic review and meta-analysis. Antibiot (Basel). 2021;10(12).","DOI":"10.3390\/antibiotics10121508"},{"issue":"1","key":"11926_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13756-023-01346-5","volume":"12","author":"A Salawudeen","year":"2023","unstructured":"Salawudeen A, Raji YE, Jibo GG, Desa MNM, Neoh HM, Masri SN, Di Gregorio S, Jamaluddin T. Epidemiology of multidrug-resistant Klebsiella pneumoniae infection in clinical setting in South-Eastern asia: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2023;12(1):142.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"5","key":"11926_CR16","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1097\/JS9.0000000000001165","volume":"110","author":"T Ali","year":"2024","unstructured":"Ali T, Habib A, Nazir Z, Ali M, Haque MA. Healthcare challenges in lmics: addressing antibiotic resistance threats, a call for comprehensive global solutions: an editorial. Int J Surg. 2024;110(5):3085\u20137.","journal-title":"Int J Surg"},{"key":"11926_CR17","doi-asserted-by":"crossref","unstructured":"Kumar NR, Balraj TA, Kempegowda SN, Prashant A. Multidrug-resistant sepsis: a critical healthcare challenge. Antibiot (Basel). 2024;13(1).","DOI":"10.3390\/antibiotics13010046"},{"issue":"1","key":"11926_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13756-021-00931-w","volume":"10","author":"K Iskandar","year":"2021","unstructured":"Iskandar K, Molinier L, Hallit S, Sartelli M, Hardcastle TC, Haque M, Lugova H, Dhingra S, Sharma P, Islam S, et al. Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture. Antimicrob Resist Infect Control. 2021;10(1):63.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"11926_CR19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12941-025-00799-3","volume":"24","author":"A Azzam","year":"2025","unstructured":"Azzam A, Salem H, Nazih M, Lotfy EM, Hassan FE, Khaled H. Prevalence, trends, and molecular insights into colistin resistance among gram-negative bacteria in egypt: a systematic review and meta-analysis. Ann Clin Microbiol Antimicrob. 2025;24(1):32.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"11926_CR20","doi-asserted-by":"publisher","first-page":"1424765","DOI":"10.3389\/fphar.2024.1424765","volume":"15","author":"S Yang","year":"2024","unstructured":"Yang S, Wang H, Zhao D, Zhang S, Hu C. Polymyxins: recent advances and challenges. Front Pharmacol. 2024;15:1424765.","journal-title":"Front Pharmacol"},{"key":"11926_CR21","doi-asserted-by":"crossref","unstructured":"Husna A, Rahman MM, Badruzzaman ATM, Sikder MH, Islam MR, Rahman MT, Alam J, Ashour HM. Extended-Spectrum Beta-Lactamases (ESBL): challenges and opportunities. Biomedicines. 2023;11(11).","DOI":"10.3390\/biomedicines11112937"},{"issue":"2","key":"11926_CR22","doi-asserted-by":"publisher","first-page":"e201","DOI":"10.1016\/S2214-109X(23)00539-9","volume":"12","author":"C Antimicrobial Resistance","year":"2024","unstructured":"Antimicrobial Resistance C. The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis. Lancet Glob Health. 2024;12(2):e201\u201316.","journal-title":"Lancet Glob Health"},{"key":"11926_CR23","first-page":"475","volume":"13","author":"G Adwan","year":"2020","unstructured":"Adwan G, Owda M, Abu-Hijleh A. Prevalence of capsular polysaccharide genes and antibiotic resistance pattern of Klebsiella pneumoniae in Palestine. Jordan J Biol Sci. 2020;13:475\u201382.","journal-title":"Jordan J Biol Sci"},{"issue":"3","key":"11926_CR24","first-page":"133","volume":"9","author":"G Tayh","year":"2021","unstructured":"Tayh G, Al Laham N, Fhoula I, Abedelateef N, El-Laham M, Elkader Elottol A, Ben Slama K. Frequency and antibiotics resistance of Extended-Spectrum Beta-Lactamase (ESBLs) producing Escherichia coli and Klebsiella pneumoniae isolated from patients in Gaza Strip, Palestine. J Med Microbiol Infect Dis. 2021;9(3):133\u201341.","journal-title":"J Med Microbiol Infect Dis"},{"issue":"3","key":"11926_CR25","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"11926_CR26","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.mjafi.2021.03.026","volume":"79","author":"M Kumar","year":"2023","unstructured":"Kumar M, Tandel K, Shergill SPS, Bhalla GS, Mahajan P, Swarnim V, Sahai K, Gupta RM. Rapid detection of carbapenem resistance among gram-negative organisms directly from positive blood culture bottles. Med J Armed Forces India. 2023;79(3):267\u201374.","journal-title":"Med J Armed Forces India"},{"issue":"1","key":"11926_CR27","doi-asserted-by":"publisher","first-page":"6640009","DOI":"10.1155\/2023\/6640009","volume":"2023","author":"L Chen","year":"2023","unstructured":"Chen L, Jian J, Xie Z, Zhao P, Zhang M. Isolation and characterization of Carbapenem-Resistant Escherichia coli carrying bla(NDM) and mcr-1 from recurrent urinary tract infection patient. Can J Infect Dis Med Microbiol. 2023;2023(1):6640009.","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"0","key":"11926_CR28","first-page":"0","volume":"0","author":"meheissen m, okasha h","year":"2022","unstructured":"meheissen m, okasha h. Verification of direct methods for detection of carbapenemase producing Enterobacteriaceae from blood cultures. Microbes Infect Dis. 2022;0(0):0\u20130.","journal-title":"Microbes Infect Dis"},{"issue":"1","key":"11926_CR29","doi-asserted-by":"publisher","first-page":"26667","DOI":"10.1038\/s41598-025-12384-x","volume":"15","author":"N Mousa","year":"2025","unstructured":"Mousa N, Aiesh BM, Jomaa R, Zouneh Y, Namrouti A, Abutaha A, Al-Jabi SW, Sabateen A, Zyoud SH. Antibiotic resistance profiles and risk factors of multidrug-resistant Escherichia coli in a large tertiary care hospital in a low- and middle-income country. Sci Rep. 2025;15(1):26667.","journal-title":"Sci Rep"},{"issue":"Suppl 1","key":"11926_CR30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1469-0691.2007.01846.x","volume":"14","author":"L Drieux","year":"2008","unstructured":"Drieux L, Brossier F, Sougakoff W, Jarlier V. Phenotypic detection of extended-spectrum beta-lactamase production in enterobacteriaceae: review and bench guide. Clin Microbiol Infect. 2008;14(Suppl 1):90\u2013103.","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"11926_CR31","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1128\/JCM.00433-06","volume":"44","author":"T Spanu","year":"2006","unstructured":"Spanu T, Sanguinetti M, Tumbarello M, D\u2019Inzeo T, Fiori B, Posteraro B, Santangelo R, Cauda R, Fadda G. Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates. J Clin Microbiol. 2006;44(9):3257\u201362.","journal-title":"J Clin Microbiol"},{"issue":"11","key":"11926_CR32","first-page":"DC08","volume":"9","author":"M Kumar","year":"2015","unstructured":"Kumar M, Dutta R, Saxena S, Singhal S. Risk factor analysis in clinical isolates of ESBL and MBL (Including NDM-1) producing Escherichia coli and Klebsiella species in a tertiary care hospital. J Clin Diagn Res. 2015;9(11):DC08\u201313.","journal-title":"J Clin Diagn Res"},{"issue":"1","key":"11926_CR33","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1038\/s41598-024-53596-x","volume":"14","author":"BM Aiesh","year":"2024","unstructured":"Aiesh BM, Natsheh M, Amar M, AbuTaha S, Qadi M, AbuTaha A, Sabateen A, Zyoud SH. Epidemiology and clinical characteristics of patients with healthcare-acquired multidrug-resistant Gram-negative bacilli: a retrospective study from a tertiary care hospital. Sci Rep. 2024;14(1):3022.","journal-title":"Sci Rep"},{"issue":"8","key":"11926_CR34","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1086\/319757","volume":"32","author":"E Lautenbach","year":"2001","unstructured":"Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis. 2001;32(8):1162\u201371.","journal-title":"Clin Infect Dis"},{"key":"11926_CR35","doi-asserted-by":"publisher","first-page":"513874","DOI":"10.1155\/2009\/513874","volume":"2009","author":"RG Batchoun","year":"2009","unstructured":"Batchoun RG, Swedan SF, Shurman AM. Extended spectrum beta-Lactamases among Gram-Negative bacterial isolates from clinical specimens in three major hospitals in Northern Jordan. Int J Microbiol. 2009;2009:513874.","journal-title":"Int J Microbiol"},{"issue":"1","key":"11926_CR36","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s44337-024-00094-8","volume":"1","author":"M Almakrami","year":"2024","unstructured":"Almakrami M, Salmen M, Aldashel YA, Alyami MH, Alquraishah N, AlZureea M, Almakrami J. Prevalence of multidrug-, extensively drug-, and pandrug-resistant bacteria in clinical isolates from King Khaled Hospital, Najran, Saudi Arabia. Discov Med. 2024;1(1):108.","journal-title":"Discov Med"},{"issue":"1","key":"11926_CR37","first-page":"11","volume":"5","author":"S Patolia","year":"2018","unstructured":"Patolia S, Abate G, Patel N, Patolia S, Frey S. Risk factors and outcomes for multidrug-resistant Gram-negative bacilli bacteremia. Ther Adv Infect Dis. 2018;5(1):11\u20138.","journal-title":"Ther Adv Infect Dis"},{"issue":"1","key":"11926_CR38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3329\/bjm.v24i1.1231","volume":"24","author":"DJ Gomes","year":"1970","unstructured":"Gomes DJ, Rahman SR, Lina TT. Multiple-Antibiotic resistance mediated by plasmids and integrons in Uropathogenic\u2009<\u2009i\u2009>\u2009Escherichia coli\u2009and Klebsiella pneumoniae. Bangladesh J Microbiol. 1970;24(1):19\u201323.","journal-title":"Bangladesh J Microbiol"},{"key":"11926_CR39","doi-asserted-by":"crossref","unstructured":"Aqel AA, Al-Matarneh TM, Al-Tarawneh TK, Alnawayseh T, Alsbou M, Gaber Y. Monitoring of antibiotic resistance patterns within Al-Karak governmental Hospital, Jordan, in 2022. Antibiot (Basel). 2024;13(12).","DOI":"10.3390\/antibiotics13121172"},{"key":"11926_CR40","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ijid.2019.04.004","volume":"83","author":"D Al Rahmany","year":"2019","unstructured":"Al Rahmany D, Albeloushi A, Alreesi I, Alzaabi A, Alreesi M, Pontiggia L, Ghazi IM. Exploring bacterial resistance in Northern Oman, a foundation for implementing evidence-based antimicrobial stewardship program. Int J Infect Dis. 2019;83:77\u201382.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"11926_CR41","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1186\/s12879-021-06245-x","volume":"21","author":"AJ Massinga","year":"2021","unstructured":"Massinga AJ, Garrine M, Messa A Jr., Nobela NA, Boisen N, Massora S, Cossa A, Varo R, Sitoe A, Hurtado JC, et al. Klebsiella spp. Cause severe and fatal disease in Mozambican children: antimicrobial resistance profile and molecular characterization. BMC Infect Dis. 2021;21(1):526.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"11926_CR42","doi-asserted-by":"publisher","first-page":"78","DOI":"10.21608\/mjmr.2022.221691","volume":"30","author":"D Kotb","year":"2019","unstructured":"Kotb D, Mahmoud M, Mahdi W, Khairy R. Prevalence and antimicrobial resistance of urinary Ract infections in upper Egypt. Minia J Med Res. 2019;30(4):78\u201385.","journal-title":"Minia J Med Res"},{"issue":"1","key":"11926_CR43","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1186\/s12879-024-09811-1","volume":"24","author":"M Worku","year":"2024","unstructured":"Worku M, Belay S, Molla T, Aynalem M, Assefa M. Prevalence and antimicrobial susceptibility pattern of Klebsiella pneumonia isolated from various clinical specimens at the university of Gondar comprehensive specialized Hospital, Northwest Ethiopia. BMC Infect Dis. 2024;24(1):917.","journal-title":"BMC Infect Dis"},{"key":"11926_CR44","doi-asserted-by":"crossref","unstructured":"Osman EA, Yokoyama M, Altayb HN, Cantillon D, Wille J, Seifert H, Higgins PG, Al-Hassan L. Klebsiella pneumonia in Sudan: multidrug resistance, polyclonal dissemination, and virulence. Antibiot (Basel). 2023;12(2).","DOI":"10.3390\/antibiotics12020233"},{"issue":"1\u20132","key":"11926_CR45","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10123-018-0006-1","volume":"21","author":"A Humayun","year":"2018","unstructured":"Humayun A, Siddiqui FM, Akram N, Saleem S, Ali A, Iqbal T, Kumar A, Kamran R, Bokhari H. Incidence of metallo-beta-lactamase-producing Klebsiella pneumoniae isolates from hospital setting in Pakistan. Int Microbiol. 2018;21(1\u20132):73\u20138.","journal-title":"Int Microbiol"},{"issue":"1","key":"11926_CR46","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1186\/s12889-024-20474-0","volume":"24","author":"R Itani","year":"2024","unstructured":"Itani R, Khojah HMJ, Kibrit R, Raychouni H, Shuhaiber P, Dib C, Hassan M, Mukattash TL, El-Lakany A. Risk factors associated with multidrug-resistant Klebsiella pneumonia infections: a multicenter observational study in Lebanese hospitals. BMC Public Health. 2024;24(1):2958.","journal-title":"BMC Public Health"},{"key":"11926_CR47","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.2147\/IDR.S366808","volume":"15","author":"X Wang","year":"2022","unstructured":"Wang X, Li Q, Kang J, Yin D, Li X, Wang S, Guo Q, Song Y, Wang J, Duan J. Mortality risk factors and prognostic analysis of patients with Multi-Drug resistant enterobacterales infection. Infect Drug Resist. 2022;15:3225\u201337.","journal-title":"Infect Drug Resist"},{"key":"11926_CR48","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.2147\/IDR.S386311","volume":"16","author":"C Wu","year":"2023","unstructured":"Wu C, Lu J, Ruan L, Yao J. Tracking epidemiological characteristics and risk factors of Multi-Drug resistant bacteria in intensive care units. Infect Drug Resist. 2023;16:1499\u2013509.","journal-title":"Infect Drug Resist"},{"issue":"4","key":"11926_CR49","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jiph.2016.08.007","volume":"10","author":"M Frieri","year":"2017","unstructured":"Frieri M, Kumar K, Boutin A. Antibiotic resistance. J Infect Public Health. 2017;10(4):369\u201378.","journal-title":"J Infect Public Health"},{"issue":"12","key":"11926_CR50","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.15537\/smj.2016.12.15739","volume":"37","author":"MM Alawi","year":"2016","unstructured":"Alawi MM, Darwesh BM. A Stepwise introduction of a successful antimicrobial stewardship program. Experience from a tertiary care university hospital in Western, Saudi Arabia. Saudi Med J. 2016;37(12):1350\u20138.","journal-title":"Saudi Med J"},{"key":"11926_CR51","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13756-019-0471-0","volume":"8","author":"D Nathwani","year":"2019","unstructured":"Nathwani D, Varghese D, Stephens J, Ansari W, Martin S, Charbonneau C. Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review. Antimicrob Resist Infect Control. 2019;8:35.","journal-title":"Antimicrob Resist Infect Control"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11926-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11926-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11926-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:03:42Z","timestamp":1761696222000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11926-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11926"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11926-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol, which was based on a review of patients\u2019 clinical records, received approval from the\n                      Institutional Review Board (IRB) of An-Najah National University\n                      , with authorization granted to access hospital records from An-Najah National University Hospital. Given the retrospective nature of the study and the use of anonymized data, the IRB waived the need for informed consent. All study procedures adhered to the ethical principles of the Declaration of Helsinki and complied with applicable guidelines and regulations. Strict measures were taken to safeguard confidentiality, with data used exclusively for research purposes and patient identifiers replaced by numerical codes to preserve privacy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1421"}}